NCT01562743View on ClinicalTrials.gov

A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

185

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Idiopathic Restless Legs Syndrome
Interventions
DRUG

SPM 962

Tansdermal patch

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

NCT01562743 - A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome | Biotech Hunter | Biotech Hunter